Neuromuscular Depolarizing Agents
"Neuromuscular Depolarizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation.
| Descriptor ID |
D009467
|
| MeSH Number(s) |
D27.505.696.663.700.710.550
|
| Concept/Terms |
Neuromuscular Depolarizing Agents- Neuromuscular Depolarizing Agents
- Agents, Neuromuscular Depolarizing
- Depolarizing Agents, Neuromuscular
- Depolarizing Blockers
- Blockers, Depolarizing
- Depolarizing Muscle Relaxants
- Relaxants, Depolarizing Muscle
- Muscle Relaxants, Depolarizing
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Depolarizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Depolarizing Agents".
This graph shows the total number of publications written about "Neuromuscular Depolarizing Agents" by people in this website by year, and whether "Neuromuscular Depolarizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuromuscular Depolarizing Agents" by people in Profiles.
-
Carlson RT, Shah S, Wells E, Fertel BS, Campbell MJ. Post-intubation analgesia and sedation following succinylcholine vs. rocuronium in the emergency department. Am J Emerg Med. 2023 09; 71:99-103.
-
Litman RS, Smith VI, Larach MG, Mayes L, Shukry M, Theroux MC, Watt S, Wong CA. Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia. Anesth Analg. 2019 04; 128(4):652-659.
-
Osaka Y, Morita Y. A case of 28 seconds asystole after a stimulus for modified electroconvulsive therapy. J Clin Anesth. 2018 06; 47:3.
-
Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med. 2012 Mar; 59(3):165-75.e1.
-
Zisselman MH, Jaffe RL. ECT in the treatment of a patient with catatonia: consent and complications. Am J Psychiatry. 2010 Feb; 167(2):127-32.
-
Theroux MC, Rose JB, Iyengar S, Katz MS. Succinylcholine pretreatment using gallamine or mivacurium during rapid sequence induction in children: a randomized, controlled study. J Clin Anesth. 2001 Jun; 13(4):287-92.
-
Rose JB, Theroux MC, Katz MS. The potency of succinylcholine in obese adolescents. Anesth Analg. 2000 Mar; 90(3):576-8.
-
Miguel R, Witkowski T, Nagashima H, Fragen R, Bartkowski R, Foldes FF, Shanks C. Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholine. Anesthesiology. 1999 Dec; 91(6):1648-54.
-
Lidsky TI, Banerjee SP. Glutamatergic effects and depolarization block. Trends Neurosci. 1997 Sep; 20(9):393; author reply 394-5.
-
Ali HH, Lien CA, Witkowski T, Brull SJ, Stout RG, Bartkowski R, Silverman DG, Patel S, Ascher JA, Goudsouzian NG. Efficacy and safety of divided dose administration of mivacurium for a 90-second tracheal intubation. J Clin Anesth. 1996 Jun; 8(4):276-81.